Shigella: Antibiotic-Resistance Mechanisms And New Horizons For Treatment

References

• Kahsay AG, Muthupandian S. A review on sero diversity and antimicrobial resistance patterns of Shigella species in Africa, Asia and South America, 2001–2014. BMC Res Notes. 2016;9(1):422. doi:10.1186/s13104-016-2236-727576729
   PubMedGoogle Scholar
• Puzari M, Sharma M, Chetia P. Emergence of antibiotic resistant Shigella species: a matter of concern. J Infect Public Health. 2018;11(4):451–454. doi:10.1016/j.jiph.2017.09.02529066021
   PubMed Web of Science ®Google Scholar
• Qu F, Bao C, Chen S, et al. Genotypes and antimicrobial profiles of Shigella sonnei isolates from diarrheal patients circulating in Beijing between 2002 and 2007. Diagn Microbiol Infect Dis. 2012;74(2):166–170. doi:10.1016/j.diagmicrobio.2012.06.02622858547
   PubMed Web of Science ®Google Scholar
• Organization WH. Antimicrobial Resistance: Global Report on Surveillance. World Health Organization; 2014.
   Google Scholar
• Grimont F, Lejay-Collin M, Talukder KA, et al. Identification of a group of shigella-like isolates as Shigella boydii 20. J Med Microbiol. 2007;56(6):749–754. doi:10.1099/jmm.0.46818-017510258
   PubMed Web of Science ®Google Scholar
• Raja SB, Murali MR, Devaraj SN. Differential expression of ompC and ompF in multidrug-resistant Shigella dysenteriae and Shigella flexneri by aqueous extract of Aegle marmelos, altering its susceptibility toward beta-lactam antibiotics. Diagn Microbiol Infect Dis. 2008;61(3):321–328. doi:10.1016/j.diagmicrobio.2008.02.00618358664
   PubMed Web of Science ®Google Scholar
• Taneja N, Mewara A. Shigellosis: epidemiology in India. Indian J Med Res. 2016;143(5):565–576. doi:10.4103/0971-5916.18710427487999
   PubMed Web of Science ®Google Scholar
• Qiu S, Wang Y, Xu X, et al. Multidrug-resistant atypical variants of Shigella flexneri in China. Emerg Infect Dis. 2013;19(7):1147. doi:10.3201/eid1909.13068223763754
   PubMed Web of Science ®Google Scholar
• Traa BS, Walker CLF, Munos M, Black RE. Antibiotics for the treatment of dysentery in children. Int J Epidemiol. 2010;39(suppl_1):i70–i84. doi:10.1093/ije/dyq02420348130
   PubMed Web of Science ®Google Scholar
• Bhattacharya D, Bhattacharya H, Thamizhmani R, et al. Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011. Eur J Clin Microbiol Infect Dis. 2014;33(2):157–170. doi:10.1007/s10096-013-1937-223990135
   PubMed Web of Science ®Google Scholar
• Shahsavan S, Owlia P, Lari AR, Bakhshi B, Nobakht M. Investigation of efflux-mediated tetracycline resistance in Shigella isolates using the inhibitor and real time polymerase chain reaction method. Iran J Pathol. 2017;12(1):53.29760753
   PubMedGoogle Scholar
• Poole K. Outer membranes and efflux: the path to multidrug resistance in gram-negative bacteria. Curr Pharm Biotechnol. 2002;3(2):77–98. doi:10.2174/138920102337845412022261
   PubMedGoogle Scholar
• Kar AK, Ghosh AS, Chauhan K, et al. Involvement of a 43-kilodalton outer membrane protein in beta-lactam resistance of Shigella dysenteriae. Antimicrob Agents Chemother. 1997;41(10):2302–2304.9333070
   PubMed Web of Science ®Google Scholar
• Ghosh AS, Kar AK, Kundu M. Impaired imipenem uptake associated with alterations in outer membrane proteins and lipopolysaccharides in imipenem-resistant Shigella dysenteriae. J Antimicrob Chemother. 1999;43(2):195–201. doi:10.1093/jac/43.2.19511252324
   PubMed Web of Science ®Google Scholar
• Tran EN, Papadopoulos M, Morona R. Relationship between O-antigen chain length and resistance to colicin E2 in Shigella flexneri. Microbiology. 2014;160(Pt 3):589–601. doi:10.1099/mic.0.074955-024425769
   PubMed Web of Science ®Google Scholar
• Koseoglu VK, Hall CP, Rodriguez-Lopez EM, Agaisse H. The autotransporter IcsA promotes Shigella flexneri biofilm formation in presence of bile salts. Infect Immun. 2019. doi:10.1128/iai.00861-18
   Web of Science ®Google Scholar
• Sun J, Deng Z, Yan A. Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations. Biochem Biophys Res Commun. 2014;453(2):254–267. doi:10.1016/j.bbrc.2014.05.09024878531
   PubMed Web of Science ®Google Scholar
• Yang H, Duan G, Zhu J, et al. The AcrAB-TolC pump is involved in multidrug resistance in clinical Shigella flexneri isolates. Microb Drug Resist. 2008;14(4):245–249. doi:10.1089/mdr.2008.084719035770
   PubMed Web of Science ®Google Scholar
• Nickerson KP, Chanin RB, Sistrunk JR, et al. Analysis of Shigella flexneri resistance, biofilm formation, and transcriptional profile in response to bile salts. Infect Immun. 2017;85(6). doi:10.1128/iai.01067-16
   Web of Science ®Google Scholar
• Kim JY, Kim SH, Jeon SM, Park MS, Rhie HG, Lee BK. Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea. Clin Microbiol Infect. 2008;14(8):760–765. doi:10.1111/j.1469-0691.2008.02033.x18727800
   PubMed Web of Science ®Google Scholar
• Taneja N, Mishra A, Kumar A, Verma G, Sharma M. Enhanced resistance to fluoroquinolones in laboratory-grown mutants & clinical isolates of Shigella due to synergism between efflux pump expression & mutations in quinolone resistance determining region. Indian J Med Res. 2015;141(1):81–89.25857499
   PubMed Web of Science ®Google Scholar
• Edgar R, Bibi E. MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition. J Bacteriol. 1997;179(7):2274–2280. doi:10.1128/jb.179.7.2274-2280.19979079913
   PubMed Web of Science ®Google Scholar
• Rahman M, Shoma S, Rashid H, Siddique AK, Nair GB, Sack DA. Extended-spectrum beta-lactamase-mediated third-generation cephalosporin resistance in Shigella isolates in Bangladesh. J Antimicrob Chemother. 2004;54(4):846–847. doi:10.1093/jac/dkh41315329365
   PubMed Web of Science ®Google Scholar
• Fortineau N, Naas T, Gaillot O, Nordmann P. SHV-type extended-spectrum beta-lactamase in a Shigella flexneri clinical isolate. J Antimicrob Chemother. 2001;47(5):685–688. doi:10.1093/jac/47.5.68511328785
   PubMed Web of Science ®Google Scholar
• Matar GM, Jaafar R, Sabra A, et al. First detection and sequence analysis of the bla-CTX-M-15 gene in lebanese isolates of extended-spectrum-beta-lactamase-producing Shigella sonnei. Ann Trop Med Parasitol. 2007;101(6):511–517. doi:10.1179/136485907x19386017716434
   PubMed Web of Science ®Google Scholar
• Sabra AH, Araj GF, Kattar MM, et al. Molecular characterization of ESBL-producing Shigella sonnei isolates from patients with bacilliary dysentery in Lebanon. J Infect Dev Ctries. 2009;3(4):300–305.19759494
   PubMed Web of Science ®Google Scholar
• Alici O, Acikgoz ZC, Gocer S, Gamberzade S, Karahocagil MK. [Short communication: prevalence of extended spectrum beta-lactamases in gram negative rods: data of 2001–2004 period]. Mikrobiyol Bul. 2006;40(4):355–361.17205693
   PubMedGoogle Scholar
• Kim S, Kim J, Kang Y, Park Y, Lee B. Occurrence of extended-spectrum beta-lactamases in members of the genus Shigella in the Republic of Korea. J Clin Microbiol. 2004;42(11):5264–5269. doi:10.1128/jcm.42.11.5264-5269.200415528724
   PubMed Web of Science ®Google Scholar
• Xiong Z, Li T, Xu Y, Li J. Detection of CTX-M-14 extended-spectrum beta-lactamase in shigella sonnei isolates from China. J Infect. 2007;55(5):e125–e128. doi:10.1016/j.jinf.2007.07.01717767959
   PubMedGoogle Scholar
• Vasilev V, Japheth R, Yishai R, et al. Extended-spectrum beta-lactamase-producing Shigella strains in Israel, 2000–2004. Eur J Clin Microbiol Infect Dis. 2007;26(3):189–194. doi:10.1007/s10096-007-0263-y17265070
   PubMed Web of Science ®Google Scholar
• Ranjbar R, Ghazi FM, Farshad S, et al. The occurrence of extended-spectrum beta-lactamase producing Shigella spp. in Tehran, Iran. Iran J Microbiol. 2013;5(2):108–112.23825726
   PubMedGoogle Scholar
• Andres P, Petroni A, Faccone D, et al. Extended-spectrum beta-lactamases in Shigella flexneri from Argentina: first report of TOHO-1 outside Japan. Int J Antimicrob Agents. 2005;25(6):501–507. doi:10.1016/j.ijantimicag.2005.02.01615878653
   PubMed Web of Science ®Google Scholar
• Bialvaei AZ, Pourlak T, Aghamali M, Asgharzadeh M, Gholizadeh P, Kafil HS. The prevalence of CTX-M-15 extended-spectrum beta-lactamases among Salmonella spp. and Shigella spp. isolated from three Iranian hospitals. Eur J Microbiol Immunol (Bp). 2017;7(2):133–137. doi:10.1556/1886.2017.0000428690880
   PubMedGoogle Scholar
• Kim JS, Kim J, Jeon SE, et al. Complete nucleotide sequence of the IncI1 plasmid pSH4469 encoding CTX-M-15 extended-spectrum beta-lactamase in a clinical isolate of Shigella sonnei from an outbreak in the Republic of Korea. Int J Antimicrob Agents. 2014;44(6):533–537. doi:10.1016/j.ijantimicag.2014.08.00725446906
   PubMed Web of Science ®Google Scholar
• Kim JS, Kim S, Park J, et al. Plasmid-mediated transfer of CTX-M-55 extended-spectrum beta-lactamase among different strains of Salmonella and Shigella spp. in the Republic of Korea. Diagn Microbiol Infect Dis. 2017;89(1):86–88. doi:10.1016/j.diagmicrobio.2017.03.01428689895
   PubMed Web of Science ®Google Scholar
• Li J, Li B, Ni Y, Sun J. Molecular characterization of the extended-spectrum beta-lactamase (ESBL)-producing Shigella spp. in Shanghai. Eur J Clin Microbiol Infect Dis. 2015;34(3):447–451. doi:10.1007/s10096-014-2244-225252628
   PubMed Web of Science ®Google Scholar
• Holt KE, Thieu Nga TV, Thanh DP, et al. Tracking the establishment of local endemic populations of an emergent enteric pathogen. Proc Natl Acad Sci U S A. 2013;110(43):17522–17527. doi:10.1073/pnas.130863211024082120
   PubMed Web of Science ®Google Scholar
• Liu Y, Cheng Y, Yang H, et al. Characterization of extended-spectrum beta-lactamase genes of Shigella flexneri isolates with fosfomycin resistance from patients in China. Ann Lab Med. 2017;37(5):415–419. doi:10.3343/alm.2017.37.5.41528643490
   PubMed Web of Science ®Google Scholar
• Zhang R, Zhou HW, Cai JC, et al. Serotypes and extended-spectrum beta-lactamase types of clinical isolates of Shigella spp. from the Zhejiang province of China. Diagn Microbiol Infect Dis. 2011;69(1):98–104. doi:10.1016/j.diagmicrobio.2010.08.02721146721
   PubMed Web of Science ®Google Scholar
• Liu G, Qian H, Tang B, et al. Prevalence and characterisation of third-generation cephalosporin-resistant Shigella flexneri isolates from Jiangsu Province, China, 2013–2015. J Glob Antimicrob Resist. 2018;15:283–287. doi:10.1016/j.jgar.2018.08.01230144637
   PubMed Web of Science ®Google Scholar
• Rashid H, Rahman M. Possible transfer of plasmid mediated third generation cephalosporin resistance between Escherichia coli and Shigella sonnei in the human gut. Infect Genet Evol. 2015;30:15–18. doi:10.1016/j.meegid.2014.11.02325461693
   PubMed Web of Science ®Google Scholar
• Qu F, Ying Z, Zhang C, et al. Plasmid-encoding extended-spectrum beta-lactamase CTX-M-55 in a clinical Shigella sonnei strain, China. Future Microbiol. 2014;9(10):1143–1150. doi:10.2217/fmb.14.5325405884
   PubMed Web of Science ®Google Scholar
• Thamizhmani R, Rhagavan R, Sugunan AP, Vijayachari P. VIM- and IMP-type metallo-beta-lactamase-producing Shigella spp. in childhood diarrhea from Andaman Islands. Infect Dis (Lond). 2015;47(10):749–750. doi:10.3109/23744235.2015.102287425768231
   PubMed Web of Science ®Google Scholar
• O’Hara K, Haruta S, Sawai T, Tsunoda M, Iyobe S. Novel metallo beta-lactamase mediated by a Shigella flexneri plasmid. FEMS Microbiol Lett. 1998;162(2):201–206. doi:10.1111/j.1574-6968.1998.tb12999.x9627953
   PubMed Web of Science ®Google Scholar
• Iyobe S, Kusadokoro H, Ozaki J, et al. Amino acid substitutions in a variant of IMP-1 metallo-beta-lactamase. Antimicrob Agents Chemother. 2000;44(8):2023–2027. doi:10.1128/aac.44.8.2023-2027.200010898670
   PubMed Web of Science ®Google Scholar
• Sambe-Ba B, Seck A, Wane AA, Fall-Niang NK, Gassama-Sow A. [Sensitivity to antibiotics and genetic support to resistance of Shigella flexneri strains isolated in Dakar from 2001 to 2010]. Bull Soc Pathol Exot. 2013;106(2):89–94. doi:10.1007/s13149-013-0283-z23483461
   PubMedGoogle Scholar
• Huang IF, Chiu CH, Wang MH, Wu CY, Hsieh KS, Chiou CC. Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: first report of plasmid-mediated CMY-2-type AmpC beta-lactamase resistance in S. sonnei. J Clin Microbiol. 2005;43(6):2608–2612. doi:10.1128/jcm.43.6.2608-2612.200515956372
   PubMed Web of Science ®Google Scholar
• Tajbakhsh M, Garcia Migura L, Rahbar M, et al. Antimicrobial-resistant Shigella infections from Iran: an overlooked problem? J Antimicrob Chemother. 2012;67(5):1128–1133. doi:10.1093/jac/dks02322345385
   PubMed Web of Science ®Google Scholar
• Ayala AT, Acuna HM, Calvo MT, Morales JL, Chacon EC. [Emergence of CMY-2-type plasmid-mediated AmpC beta-lactamase in Shigella sonnei and Salmonella spp. in Costa Rica, 2003–2015]. Rev Panam Salud Publica. 2016;40(1):70–75.27706388
   PubMed Web of Science ®Google Scholar
• Zamanlou S, Ahangarzadeh Rezaee M, Aghazadeh M, Ghotaslou R, Babaie F, Khalili Y. Characterization of integrons, extended-spectrum beta-lactamases, AmpC cephalosporinase, quinolone resistance, and molecular typing of Shigella spp. from Iran. Infect Dis (Lond). 2018;50(8):616–624. doi:10.1080/23744235.2018.145522229595080
   PubMed Web of Science ®Google Scholar
• Zhang CL, Liu QZ, Wang J, Chu X, Shen LM, Guo YY. Epidemic and virulence characteristic of Shigella spp. with extended-spectrum cephalosporin resistance in Xiaoshan District, Hangzhou, China. BMC Infect Dis. 2014;14:260. doi:10.1186/1471-2334-14-26024886028
   PubMed Web of Science ®Google Scholar
• Cui X, Wang J, Yang C, et al. Prevalence and antimicrobial resistance of shigella flexneri serotype 2 variant in China. Front Microbiol. 2015;6:435. doi:10.3389/fmicb.2015.0043525999941
   PubMed Web of Science ®Google Scholar
• Anandan S, Muthuirulandi Sethuvel DP, Gajendiren R, Verghese VP, Walia K, Veeraraghavan B. Molecular characterization of antimicrobial resistance in clinical Shigella isolates during 2014 and 2015: trends in South India. Germs. 2017;7(3):115–122. doi:10.18683/germs.2017.111628932711
   PubMedGoogle Scholar
• Toro C, Farfán M, Contreras I, et al. Genetic analysis of antibiotic-resistance determinants in multidrug-resistant Shigella strains isolated from Chilean children. Epidemiol Infect. 2005;133(1):81–86. doi:10.1017/S095026880400304815724714
   PubMed Web of Science ®Google Scholar
• Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins and carbapenems in gram-negative bacterial pathogens. Int J Med Microbiol. 2010;300(6):371–379. doi:10.1016/j.ijmm.2010.04.00520537585
   PubMed Web of Science ®Google Scholar
• Cui X, Yang C, Wang J, et al. Antimicrobial resistance of Shigella flexneri serotype 1b isolates in China. PLoS One. 2015;10(6):e0129009. doi:10.1371/journal.pone.012900926039698
   PubMed Web of Science ®Google Scholar
• Siu LK, Lo JY, Yuen KY, Chau PY, Ng MH, Ho PL. beta-lactamases in Shigella flexneri isolates from Hong Kong and Shanghai and a novel OXA-1-like beta-lactamase, OXA-30. Antimicrob Agents Chemother. 2000;44(8):2034–2038. doi:10.1128/aac.44.8.2034-2038.200010898672
   PubMed Web of Science ®Google Scholar
• Navia MM, Capitano L, Ruiz J, et al. Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania. J Clin Microbiol. 1999;37(10):3113–3117.10488163
   PubMed Web of Science ®Google Scholar
• Azmi IJ, Khajanchi BK, Akter F, et al. Fluoroquinolone resistance mechanisms of Shigella flexneri isolated in Bangladesh. PLoS One. 2014;9(7):e102533. doi:10.1371/journal.pone.010253325028972
   PubMed Web of Science ®Google Scholar
• Hu LF, Li JB, Ye Y, Li X. Mutations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in clinical strains of fluoroquinolone-resistant Shigella in Anhui, China. J Microbiol. 2007;45(2):168–170.17483803
   PubMed Web of Science ®Google Scholar
• Ramana J, Ramana J. Structural Insights into the fluoroquinolone resistance mechanism of Shigella flexneri DNA gyrase and topoisomerase IV. Microb Drug Resist. 2016;22(5):404–411. doi:10.1089/mdr.2015.001826859259
   PubMed Web of Science ®Google Scholar
• Nuesch-Inderbinen M, Heini N, Zurfluh K, Althaus D, Hachler H, Stephan R. Shigella antimicrobial drug resistance mechanisms, 2004–2014. Emerg Infect Dis. 2016;22(6):1083–1085. doi:10.3201/eid2206.15208827191035
   PubMed Web of Science ®Google Scholar
• Xue C, Cai J, Kang H, et al. Two novel mutations in parE among Shigella flexneri isolated from Jiangsu Province of China, 2016. Ann Transl Med. 2018;6(15):306. doi:10.21037/atm.2018.07.1130211194
   PubMed Web of Science ®Google Scholar
• Dutta S, Kawamura Y, Ezaki T, Nair GB, Iida K, Yoshida S. Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India. Antimicrob Agents Chemother. 2005;49(4):1660–1661. doi:10.1128/aac.49.4.1660-1661.200515793166
   PubMed Web of Science ®Google Scholar
• Gu B, Qin TT, Fan WT, et al. Novel mutations in gyrA and parC among Shigella sonnei strains from Jiangsu Province of China, 2002–2011. Int J Infect Dis. 2017;59:44–49. doi:10.1016/j.ijid.2017.03.02328392317
   PubMed Web of Science ®Google Scholar
• Das A, Natarajan M, Mandal J, Herman C. The emergence of quinolone resistant Shigella sonnei, Pondicherry, India. PLoS One. 2016;11(8):e0160290. doi:10.1371/journal.pone.016029027494616
   PubMed Web of Science ®Google Scholar
• Zhang WX, Chen HY, Tu LH, Xi MF, Chen M, Zhang J. Fluoroquinolone resistance mechanisms in Shigella isolates in Shanghai, China, between 2010 and 2015. Microb Drug Resist. 2019;25(2):212–218. doi:10.1089/mdr.2018.011330307807
   PubMed Web of Science ®Google Scholar
• Zhu Z, Cao M, Zhou X, Li B, Zhang J. Epidemic characterization and molecular genotyping of Shigella flexneri isolated from calves with diarrhea in Northwest China. Antimicrob Resist Infect Control. 2017;6:92. doi:10.1186/s13756-017-0252-628878891
   PubMed Web of Science ®Google Scholar
• Bowen A, Hurd J, Hoover C, et al. Importation and domestic transmission of Shigella sonnei resistant to ciprofloxacin - United States, May 2014-February 2015. MMWR Morb Mortal Wkly Rep. 2015;64(12):318–320.25837241
   PubMed Web of Science ®Google Scholar
• Pu XY, Pan JC, Wang HQ, Zhang W, Huang ZC, Gu YM. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China. J Antimicrob Chemother. 2009;63(5):917–920. doi:10.1093/jac/dkp08719297378
   PubMed Web of Science ®Google Scholar
• Hata M, Suzuki M, Matsumoto M, et al. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother. 2005;49(2):801–803. doi:10.1128/aac.49.2.801-803.200515673773
   PubMed Web of Science ®Google Scholar
• Qin T, Qian H, Fan W, et al. Newest data on fluoroquinolone resistance mechanism of Shigella flexneri isolates in Jiangsu Province of China. Antimicrob Resist Infect Control. 2017;6:97. doi:10.1186/s13756-017-0249-128932390
   PubMed Web of Science ®Google Scholar
• Pu XY, Pan JC, Zhang W, Zheng W, Wang HQ, Gu YM. Quinolone resistance-determining region mutations and the plasmid-mediated quinolone resistance gene qnrS played important roles in decreased susceptibility to fluoroquinolones among Shigella isolates in southeast China between 1998 and 2013. Int J Antimicrob Agents. 2015;45(4):438–439. doi:10.1016/j.ijantimicag.2014.12.00425593013
   PubMed Web of Science ®Google Scholar
• Pu XY, Gu Y, Li J, Song SJ, Lu Z. Characterization of the complete sequences and stability of plasmids carrying the genes aac(6ʹ)-Ib-cr or qnrS in Shigella flexneri in the Hangzhou area of China. World J Microbiol Biotechnol. 2018;34(6):72. doi:10.1007/s11274-018-2454-329777316
   PubMed Web of Science ®Google Scholar
• Ferjani S, Saidani M, Amine FS, Boutiba-Ben Boubaker I. Prevalence and characterization of plasmid-mediated quinolone resistance genes in extended-spectrum beta-lactamase-producing Enterobacteriaceae in a Tunisian hospital. Microb Drug Resist. 2015;21(2):158–166. doi:10.1089/mdr.2014.005325247633
   PubMed Web of Science ®Google Scholar
• Yaghoubi S, Ranjbar R, Soltan Dallal MM, Shirazi MH, Sharifi-Yazdi MK. Frequency of mutations in quinolone resistance-determining regions and plasmid-mediated quinolone resistance in Shigella isolates recovered from pediatric patients in Tehran, Iran: an Overlooked Problem. Microb Drug Resist. 2018;24(6):699–706. doi:10.1089/mdr.2017.015529148915
   PubMed Web of Science ®Google Scholar
• Yang H, Duan G, Zhu J, Zhang W, Xi Y, Fan Q. Prevalence and characterisation of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes among Shigella isolates from Henan, China, between 2001 and 2008. Int J Antimicrob Agents. 2013;42(2):173–177. doi:10.1016/j.ijantimicag.2013.04.02623796894
   PubMed Web of Science ®Google Scholar
• Perea EJ, Torres MA, Borobio MV. Synergism of fosfomycin-ampicillin and fosfomycin-chloramphenicol against Salmonella and Shigella. Antimicrob Agents Chemother. 1978;13(5):705–709. doi:10.1128/aac.13.5.705666297
   PubMed Web of Science ®Google Scholar
• Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis. 2010;10(1):43–50. doi:10.1016/s1473-3099(09)70325-120129148
   PubMed Web of Science ®Google Scholar
• Wachino J, Yamane K, Suzuki S, Kimura K, Arakawa Y. Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes. Antimicrob Agents Chemother. 2010;54(7):3061–3064. doi:10.1128/aac.01834-0920404116
   PubMed Web of Science ®Google Scholar
• Silver LL. Fosfomycin: mechanism and resistance. Cold Spring Harb Perspect Med. 2017;7(2):a025262. doi:10.1101/cshperspect.a02526228062557
   PubMed Web of Science ®Google Scholar
• Fourmy D, Yoshizawa S, Puglisi JD. Paromomycin binding induces a local conformational change in the A-site of 16 S rRNA. J Mol Biol. 1998;277(2):333–345. doi:10.1006/jmbi.1997.15519514734
   PubMed Web of Science ®Google Scholar
• Shaw PC, Liang AC, Kam KM, Ling JM. Presence of strA-strB gene within a streptomycin-resistance operon in a clinical isolate of Shigella flexneri. Pathology. 1996;28(4):356–358. doi:10.1080/003130296001693449007957
   PubMed Web of Science ®Google Scholar
• McIver CJ, White PA, Jones LA, et al. Epidemic strains of Shigella sonnei biotype g carrying integrons. J Clin Microbiol. 2002;40(4):1538–1540. doi:10.1128/jcm.40.4.1538-1540.200211923391
   PubMed Web of Science ®Google Scholar
• Iversen J, Sandvang D, Srijan A, Cam PD, Dalsgaard A. Characterization of antimicrobial resistance, plasmids, and gene cassettes in Shigella spp. from patients in vietnam. Microb Drug Resist. 2003;9(Suppl 1):S17–S24. doi:10.1089/10766290332254185614633363
   PubMed Web of Science ®Google Scholar
• Michael GB, Schwarz S. Antimicrobial resistance in zoonotic nontyphoidal Salmonella: an alarming trend? Clin Microbiol Infect. 2016;22(12):968–974. doi:10.1016/j.cmi.2016.07.03327506509
   PubMed Web of Science ®Google Scholar
• Dutta S, Jain P, Nandy S, Matsushita S, Yoshida S. Molecular characterization of serologically atypical provisional serovars of Shigella isolates from Kolkata, India. J Med Microbiol. 2014;63(Pt 12):1696–1703. doi:10.1099/jmm.0.081307-025261061
   PubMed Web of Science ®Google Scholar
• Ranjbar R, Aleo A, Giammanco GM, Dionisi AM, Sadeghifard N, Mammina C. Genetic relatedness among isolates of Shigella sonnei carrying class 2 integrons in Tehran, Iran, 2002–2003. BMC Infect Dis. 2007;7:62. doi:10.1186/1471-2334-7-6217587439
   PubMed Web of Science ®Google Scholar
• Chang CY, Lu PL, Lin CC, Lee TM, Tsai MY, Chang LL. Integron types, gene cassettes, antimicrobial resistance genes and plasmids of Shigella sonnei isolates from outbreaks and sporadic cases in Taiwan. J Med Microbiol. 2011;60(Pt 2):197–204. doi:10.1099/jmm.0.022517-020947666
   PubMed Web of Science ®Google Scholar
• Antunes P, Machado J, Sousa JC, Peixe L. Dissemination of sulfonamide resistance genes (sul1, sul2, and sul3) in Portuguese Salmonella enterica strains and relation with integrons. Antimicrob Agents Chemother. 2005;49(2):836–839. doi:10.1128/aac.49.2.836-839.200515673783
   PubMed Web of Science ®Google Scholar
• Bischoff KM, White DG, Hume ME, Poole TL, Nisbet DJ. The chloramphenicol resistance gene cmlA is disseminated on transferable plasmids that confer multiple-drug resistance in swine Escherichia coli. FEMS Microbiol Lett. 2005;243(1):285–291. doi:10.1016/j.femsle.2004.12.01715668031
   PubMed Web of Science ®Google Scholar
• Gassama Sow A, Aidara-Kane A, Barraud O, Gatet M, Denis F, Ploy MC. High prevalence of trimethoprim-resistance cassettes in class 1 and 2 integrons in Senegalese Shigella spp isolates. J Infect Dev Ctries. 2010;4(4):207–212.20440057
   PubMed Web of Science ®Google Scholar
• Muthuirulandi Sethuvel DP, Anandan S, Devanga Ragupathi NK, et al. IncFII plasmid carrying antimicrobial resistance genes in Shigella flexneri: vehicle for dissemination. J Glob Antimicrob Resist. 2019;16:215–219. doi:10.1016/j.jgar.2018.10.01430342929
   PubMed Web of Science ®Google Scholar
• Parajuli P, Deimel LP, Verma NK. Genome analysis of Shigella flexneri serotype 3b strain SFL1520 reveals significant horizontal gene acquisitions including a multidrug resistance cassette. Genome Biol Evol. 2019;11(3):776–785. doi:10.1093/gbe/evz02630715343
   PubMed Web of Science ®Google Scholar
• Tariq A, Haque A, Ali A, et al. Molecular profiling of antimicrobial resistance and integron association of multidrug-resistant clinical isolates of Shigella species from Faisalabad, Pakistan. Can J Microbiol. 2012;58(9):1047–1054. doi:10.1139/w2012-08522906205
   PubMed Web of Science ®Google Scholar
• Pazhani GP, Niyogi SK, Singh AK, et al. Molecular characterization of multidrug-resistant Shigella species isolated from epidemic and endemic cases of shigellosis in India. J Med Microbiol. 2008;57(Pt 7):856–863. doi:10.1099/jmm.0.2008/000521-018566144
   PubMed Web of Science ®Google Scholar
• Barman S, Chatterjee S, Chowdhury G, et al. Plasmid-mediated streptomycin and sulfamethoxazole resistance in Shigella flexneri 3a. Int J Antimicrob Agents. 2010;36(4):348–351. doi:10.1016/j.ijantimicag.2010.06.03720685089
   PubMed Web of Science ®Google Scholar
• Seol SY, Kim YT, Jeong YS, et al. Molecular characterization of antimicrobial resistance in Shigella sonnei isolates in Korea. J Med Microbiol. 2006;55(Pt 7):871–877. doi:10.1099/jmm.0.46441-016772414
   PubMed Web of Science ®Google Scholar
• Pan JC, Ye R, Meng DM, Zhang W, Wang HQ, Liu KZ. Molecular characteristics of class 1 and class 2 integrons and their relationships to antibiotic resistance in clinical isolates of Shigella sonnei and Shigella flexneri. J Antimicrob Chemother. 2006;58(2):288–296. doi:10.1093/jac/dkl22816766536
   PubMed Web of Science ®Google Scholar
• Hartman AB, Essiet II, Isenbarger DW, Lindler LE. Epidemiology of tetracycline resistance determinants in Shigella spp. and enteroinvasive Escherichia coli: characterization and dissemination of tet(A)-1. J Clin Microbiol. 2003;41(3):1023–1032. doi:10.1128/jcm.41.3.1023-1032.200312624025
   PubMed Web of Science ®Google Scholar
• Roberts MC. Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiol Rev. 1996;19(1):1–24. doi:10.1111/j.1574-6976.1996.tb00251.x8916553
   PubMed Web of Science ®Google Scholar
• Parajuli P, Rajput MI, Verma NK. Plasmids of Shigella flexneri serotype 1c strain Y394 provide advantages to bacteria in the host. BMC Microbiol. 2019;19(1):86. doi:10.1186/s12866-019-1455-131035948
   PubMed Web of Science ®Google Scholar
• Luck SN, Turner SA, Rajakumar K, Sakellaris H, Adler B. Ferric dicitrate transport system (Fec) of Shigella flexneri 2a YSH6000 is encoded on a novel pathogenicity island carrying multiple antibiotic resistance genes. Infect Immun. 2001;69(10):6012–6021. doi:10.1128/iai.69.10.6012-6021.200111553538
   PubMed Web of Science ®Google Scholar
• Wibberg D, Szczepanowski R, Eikmeyer F, Puhler A, Schluter A. The IncF plasmid pRSB225 isolated from a municipal wastewater treatment plant’s on-site preflooder combining antibiotic resistance and putative virulence functions is highly related to virulence plasmids identified in pathogenic E. coli isolates. Plasmid. 2013;69(2):127–137. doi:10.1016/j.plasmid.2012.11.00123212116
   PubMed Web of Science ®Google Scholar
• Allue-Guardia A, Koenig SSK, Quiros P, Muniesa M, Bono JL, Eppinger M. Closed genome and comparative phylogenetic analysis of the clinical multidrug resistant Shigella sonnei strain 866. Genome Biol Evol. 2018;10(9):2241–2247. doi:10.1093/gbe/evy16830060169
   PubMed Web of Science ®Google Scholar
• Pons MJ, Torrents de la Pena A, Mensa L, et al. Differences in tetracycline resistance determinant carriage among Shigella flexneri and Shigella sonnei are not related to different plasmid Inc-type carriage. J Glob Antimicrob Resist. 2018;13:131–134. doi:10.1016/j.jgar.2017.12.01529307861
   PubMed Web of Science ®Google Scholar
• Mandomando I, Jaintilal D, Pons MJ, et al. Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique. Antimicrob Agents Chemother. 2009;53(6):2450–2454. doi:10.1128/aac.01282-0819332670
   PubMed Web of Science ®Google Scholar
• Alizadeh-Hesar M, Bakhshi B, Najar-Peerayeh S. Clonal dissemination of a single Shigella sonnei strain among Iranian children during Fall 2012 in Tehran, I.R. Iran. Infect Genet Evol. 2015;34:260–266. doi:10.1016/j.meegid.2015.06.02426117443
   PubMed Web of Science ®Google Scholar
• Martinez-Salazar JM, Alvarez G, Gomez-Eichelmann MC. Frequency of four classes of tetracycline resistance determinants in Salmonella and Shigella spp. clinical isolates. Antimicrob Agents Chemother. 1986;30(4):630–631. doi:10.1128/aac.30.4.6303789700
   PubMed Web of Science ®Google Scholar
• Ledov VA, Golovina ME, Markina AA, et al. Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection. Vaccine. 2019;37(8):1062–1072. doi:10.1016/j.vaccine.2018.12.06730670300
   PubMed Web of Science ®Google Scholar
• Williams PCM, Berkley JA. Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence. Paediatr Int Child Health. 2018;38(sup1):S50–s65. doi:10.1080/20469047.2017.140945429790845
   PubMed Web of Science ®Google Scholar
• Schwarz S, Kehrenberg C, Doublet B, Cloeckaert A. Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol Rev. 2004;28(5):519–542. doi:10.1016/j.femsre.2004.04.00115539072
   PubMed Web of Science ®Google Scholar
• Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–168. doi:10.1016/s1473-3099(15)00424-726603172
   PubMed Web of Science ®Google Scholar
• Pham Thanh D, Thanh Tuyen H, Nguyen Thi Nguyen T, et al. Inducible colistin resistance via a disrupted plasmid-borne mcr-1 gene in a 2008 vietnamese Shigella sonnei isolate. J Antimicrob Chemother. 2016;71(8):2314–2317. doi:10.1093/jac/dkw17327246235
   PubMed Web of Science ®Google Scholar
• Schwarz S, Johnson AP. Transferable resistance to colistin: a new but old threat. J Antimicrob Chemother. 2016;71(8):2066–2070. doi:10.1093/jac/dkw27427342545
   PubMed Web of Science ®Google Scholar
• Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev. 2017;30(2):557–596. doi:10.1128/cmr.00064-1628275006
   PubMed Web of Science ®Google Scholar
• Hinchliffe P, Yang QE, Portal E, et al. Insights into the mechanistic basis of plasmid-mediated colistin resistance from crystal structures of the catalytic domain of MCR-1. Sci Rep. 2017;7:39392. doi:10.1038/srep3939228059088
   PubMed Web of Science ®Google Scholar
• Ma Q, Huang Y, Wang J, et al. Multidrug-resistant Shigella sonnei carrying the plasmid-mediated mcr-1 gene in China. Int J Antimicrob Agents. 2018;52(1):14–21. doi:10.1016/j.ijantimicag.2018.02.01929501823
   PubMed Web of Science ®Google Scholar
• Niyogi SK. Shigellosis. J Microbiol. 2005;43(2):133–143.15880088
   PubMed Web of Science ®Google Scholar
• Skold O. Resistance to trimethoprim and sulfonamides. Vet Res. 2001;32(3–4):261–273. doi:10.1051/vetres:200112311432417
   PubMed Web of Science ®Google Scholar
• Huovinen P. Resistance to trimethoprim-sulfamethoxazole. Clin Infect Dis. 2001;32(11):1608–1614. doi:10.1086/32053211340533
   PubMed Web of Science ®Google Scholar
• Peirano G, Agerso Y, Aarestrup FM, dos Prazeres Rodrigues D. Occurrence of integrons and resistance genes among sulphonamide-resistant Shigella spp. from Brazil. J Antimicrob Chemother. 2005;55(3):301–305. doi:10.1093/jac/dki01215681578
   PubMed Web of Science ®Google Scholar
• Ahmed AM, Furuta K, Shimomura K, Kasama Y, Shimamoto T. 1Genetic characterization of multidrug resistance in Shigella spp. from Japan. J Med Microbiol. 2006;55(Pt 12):1685–1691. doi:10.1099/jmm.0.46725-017108272
   PubMed Web of Science ®Google Scholar
• Miranda A, Avila B, Diaz P, et al. Emergence of plasmid-borne dfrA14 trimethoprim resistance gene in Shigella sonnei. Front Cell Infect Microbiol. 2016;6:77. doi:10.3389/fcimb.2016.0007727489797
   PubMed Web of Science ®Google Scholar
• Chun D-K, Seol S-Y. Drug resistance of Shigella and Salmonella and the inhibition and elimination of drug resistance. J Korean Soc Microbiol. 1979;14(1):27–37.
   Google Scholar
• Summers AO. Genetic linkage and horizontal gene transfer, the roots of the antibiotic multi-resistance problem. Anim Biotechnol. 2006;17(2):125–135. doi:10.1080/1049539060095721717127524
   PubMed Web of Science ®Google Scholar
• Nigro SJ, Hall RM. GIsul2, a genomic island carrying the sul2 sulphonamide resistance gene and the small mobile element CR2 found in the enterobacter cloacae subspecies cloacae type strain ATCC 13047 from 1890, Shigella flexneri ATCC 700930 from 1954 and acinetobacter baumannii ATCC 17978 from 1951. J Antimicrob Chemother. 2011;66(9):2175–2176. doi:10.1093/jac/dkr23021653606
   PubMed Web of Science ®Google Scholar
• Iqbal MS, Rahman M, Islam R, et al. Plasmid-mediated sulfamethoxazole resistance encoded by the sul2 gene in the multidrug-resistant Shigella flexneri 2a isolated from patients with acute diarrhea in Dhaka, Bangladesh. PLoS One. 2014;9(1):e85338. doi:10.1371/journal.pone.008533824416393
   PubMed Web of Science ®Google Scholar
• Salah M, Shtayeh I, Ghneim R, et al. Evaluation of Shigella species azithromycin CLSI epidemiological cutoff values and macrolide resistance genes. J Clin Microbiol. 2019;57(4). doi:10.1128/jcm.01422-18
   Web of Science ®Google Scholar
• Yousfi K, Gaudreau C, Pilon PA, et al. Genetic mechanisms behind the spread of reduced susceptibility to azithromycin in Shigella strains isolated from men who have sex with men in Quebec, Canada. Antimicrob Agents Chemother. 2019;63(2). doi:10.1128/aac.01679-18
   Web of Science ®Google Scholar
• Ingle DJ, Easton M, Valcanis M, et al. Co-circulation of multidrug-resistant Shigella among men who have sex with men, Australia. Clin Infect Dis. 2019. doi:10.1093/cid/ciz005
   Web of Science ®Google Scholar
• Borg ML, Modi A, Tostmann A, et al. Ongoing outbreak of Shigella flexneri serotype 3a in men who have sex with men in England and Wales, data from 2009–2011. Euro Surveill. 2012;17(13):20137.22490381
   PubMedGoogle Scholar
• Gaudreau C, Barkati S, Leduc JM, Pilon PA, Favreau J, Bekal S. Shigella spp. with reduced azithromycin susceptibility, Quebec, Canada, 2012–2013. Emerg Infect Dis. 2014;20(5):854–856. doi:10.3201/eid2005.13096624750584
   PubMed Web of Science ®Google Scholar
• Sjolund Karlsson M, Bowen A, Reporter R, et al. Outbreak of infections caused by Shigella sonnei with reduced susceptibility to azithromycin in the United States. Antimicrob Agents Chemother. 2013;57(3):1559–1560. doi:10.1128/aac.02360-1223274665
   PubMed Web of Science ®Google Scholar
• Darton TC, Tuyen HT, The HC, et al. Azithromycin resistance in Shigella spp. in Southeast Asia. Antimicrob Agents Chemother. 2018;62(4). doi:10.1128/aac.01748-17
   Web of Science ®Google Scholar
• Liao YS, Liu YY, Lo YC, Chiou CS. Azithromycin-nonsusceptible Shigella flexneri 3a in men who have sex with men, Taiwan, 2015–2016. Emerg Infect Dis. 2016;23(2):345–346. doi:10.3201/eid2302.16126028098533
   PubMed Web of Science ®Google Scholar
• Boumghar-Bourtchai L, Mariani-Kurkdjian P, Bingen E, et al. Macrolide-resistant Shigella sonnei. Emerg Infect Dis. 2008;14(8):1297–1299. doi:10.3201/eid1408.08014718680661
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang R, Yu Q, Chu X, Sun J, Liu Q. Decreased susceptibility to azithromycin among clinical Shigella isolates from China. Microb Drug Resist. 2017;23(5):596–601. doi:10.1089/mdr.2016.013427841958
   PubMed Web of Science ®Google Scholar
• Healy M, Huong J, Bittner T, et al. Microbial DNA typing by automated repetitive-sequence-based PCR. J Clin Microbiol. 2005;43(1):199–207. doi:10.1128/jcm.43.1.199-207.200515634972
   PubMed Web of Science ®Google Scholar
• Mannion AJ, Martin HR, Shen Z, et al. Plasmid-mediated quinolone resistance in Shigella flexneri isolated from Macaques. Front Microbiol. 2018;9:311. doi:10.3389/fmicb.2018.0031129556221
   PubMed Web of Science ®Google Scholar
• Phuc Nguyen MC, Woerther PL, Bouvet M, Andremont A, Leclercq R, Canu A. Escherichia coli as reservoir for macrolide resistance genes. Emerg Infect Dis. 2009;15(10):1648–1650. doi:10.3201/eid1510.09069619861064
   PubMed Web of Science ®Google Scholar
• Baker KS, Dallman TJ, Ashton PM, et al. Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study. Lancet Infect Dis. 2015;15(8):913–921. doi:10.1016/s1473-3099(15)00002-x25936611
   PubMed Web of Science ®Google Scholar
• Kang J, Liu L, Liu M, Wu X, Li J. Antibacterial activity of gallic acid against Shigella flexneri and its effect on biofilm formation by repressing mdoH gene expression. Food Control. 2018;94:147–154. doi:10.1016/j.foodcont.2018.07.011
   Web of Science ®Google Scholar
• Agle ME, Blaschek HP. Shigella: Survival on Produce and Biofilm Formation. Oxford: Blackwell Publishing Ltd. 2006:19–46.
   Google Scholar
• Dorman MJ, Dorman CJ. Regulatory hierarchies controlling virulence gene expression in Shigella flexneri and vibrio cholerae. Front Microbiol. 2018;9:2686. doi:10.3389/fmicb.2018.0268630473684
   PubMed Web of Science ®Google Scholar
• Ellafi A, Abdallah FB, Lagha R, Harbi B, Bakhrouf A. Biofilm production, adherence and morphological alterations of Shigella spp. Under salt conditions. Annals of microbiology. 2011;61(4):741–747. doi:10.1007/s13213-010-0190-5
   Web of Science ®Google Scholar
• Olive AJ, Kenjale R, Espina M, Moore DS, Picking WL, Picking WD. Bile salts stimulate recruitment of IpaB to the Shigella flexneri surface, where it colocalizes with IpaD at the tip of the type III secretion needle. Infect Immun. 2007;75(5):2626–2629. doi:10.1128/iai.01599-0617296762
   PubMed Web of Science ®Google Scholar
• Barta ML, Guragain M, Adam P, et al. Identification of the bile salt binding site on IpaD from Shigella flexneri and the influence of ligand binding on IpaD structure. Proteins. 2012;80(3):935–945.22423359
   PubMed Web of Science ®Google Scholar
• Xu D, Zhang W, Zhang B, Liao C, Shao Y. Characterization of a biofilm-forming Shigella flexneri phenotype due to deficiency in Hep biosynthesis. PeerJ. 2016;4:e2178. doi:10.7717/peerj.217827478696
   PubMed Web of Science ®Google Scholar
• Filho-Lima JV, Vieira EC, Nicoli JR. Antagonistic effect of Lactobacillus acidophilus, Saccharomyces boulardii and Escherichia coli combinations against experimental infections with Shigella flexneri and Salmonella enteritidis subsp. typhimurium in gnotobiotic mice. J Appl Microbiol. 2000;88(3):365–370. doi:10.1046/j.1365-2672.2000.00973.x10747216
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang L, Du M, et al. Antimicrobial activity against Shigella sonnei and probiotic properties of wild lactobacilli from fermented food. Microbiol Res. 2011;167(1):27–31. doi:10.1016/j.micres.2011.02.00621466951
   PubMed Web of Science ®Google Scholar
• Moorthy G, Murali MR, Niranjali Devaraj S. Lactobacilli inhibit Shigella dysenteriae 1 induced pro-inflammatory response and cytotoxicity in host cells via impediment of Shigella-host interactions. Dig Liver Dis. 2010;42(1):33–39. doi:10.1016/j.dld.2009.04.02119535308
   PubMedGoogle Scholar
• Zhang YC, Zhang LW, Ma W, et al. Screening of probiotic lactobacilli for inhibition of Shigella sonnei and the macromolecules involved in inhibition. Anaerobe. 2012;18(5):498–503. doi:10.1016/j.anaerobe.2012.08.00722967793
   PubMed Web of Science ®Google Scholar
• Mirnejad R, Vahdati AR, Rashidiani J, Erfani M, Piranfar V. The antimicrobial effect of lactobacillus casei culture supernatant against multiple drug resistant clinical isolates of Shigella sonnei and Shigella flexneri in vitro. Iran Red Crescent Med J. 2013;15(2):122–126. doi:10.5812/ircmj.745423682323
   PubMed Web of Science ®Google Scholar
• Ayeni AO, Ayeni FA. Antagonistic effects of lactic and acetic acid bacteria on Shigella sp. SS10 in co-culture. TAF Preventive Medicine Bulletin. 2016;15(1):27–31. doi:10.5455/pmb.1-1438753866
   Google Scholar
• Mumy KL, Chen X, Kelly CP, McCormick BA. Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events. Am J Physiol Gastrointest Liver Physiol. 2008;294(3):G599–G609. doi:10.1152/ajpgi.00391.200718032477
   PubMed Web of Science ®Google Scholar
• Rene K, Hortense G, Pascal W, et al. Activity of aqueous ethanol extract of Euphorbia prostrata ait on Shigella dysenteriae type 1-induced diarrhea in rats. Indian J Pharmacol. 2007;39(5):240–244. doi:10.4103/0253-7613.37275
   Web of Science ®Google Scholar
• Hussain SA, Patil GR, Reddi S, et al. Aloe vera (Aloe barbadensis Miller) supplemented probiotic lassi prevents Shigella infiltration from epithelial barrier into systemic blood flow in mice model. Microb Pathog. 2017;102:143–147. doi:10.1016/j.micpath.2016.11.02327914960
   PubMed Web of Science ®Google Scholar
• Kiran S, Ratho RK, Sharma P, Harjai K, Capalash N, Tiwari RP. Effect of black tea (Camellia sinensis) on virulence traits of clinical isolates of Shigella dysenteriae and Escherichia coli EPEC P2 1265 strain. Eur Food Res Technol. 2010;231(5):763–770. doi:10.1007/s00217-010-1328-1
   Web of Science ®Google Scholar
• Kouitcheu LB, Tamesse JL, Kouam J. The anti-shigellosis activity of the methanol extract of picralima nitida on Shigella dysenteriae type I induced diarrhoea in rats. BMC Complement Altern Med. 2013;13:211. doi:10.1186/1472-6882-13-21123957940
   PubMed Web of Science ®Google Scholar
• Acharyya S, Sarkar P, Saha DR, Patra A, Ramamurthy T, Bag PK. Intracellular and membrane-damaging activities of methyl gallate isolated from Terminalia chebula against multidrug-resistant Shigella spp. J Med Microbiol. 2015;64(8):901–909. doi:10.1099/jmm.0.00010726272388
   PubMed Web of Science ®Google Scholar
• Allam NG, Eldrieny EA, Mohamed AZ. Effect of combination therapy between thyme oil and ciprofloxacin on ulcer-forming Shigella flexneri. J Infect Dev Ctries. 2015;9(5):486–495. doi:10.3855/jidc.630225989168
   PubMed Web of Science ®Google Scholar
• Noubissi PA, Fokam Tagne MA, Fankem GO, Ngakou Mukam J, Wambe H, Kamgang R. Effects of crinum jagus water/ethanol extract on Shigella flexneri-induced diarrhea in rats. Evid Based Complement Alternat Med. 2019;2019:9537603. doi:10.1155/2019/953760330992711
   PubMed Web of Science ®Google Scholar
• Mosquito S, Zegarra G, Villanueva C, Ruiz J, Ochoa TJ. Effect of bovine lactoferrin on the minimum inhibitory concentrations of ampicillin and trimethoprim-sulfamethoxazole for clinical Shigella spp. strains. Biochem Cell Biol. 2012;90(3):412–416. doi:10.1139/o11-06622397495
   PubMed Web of Science ®Google Scholar
• Chai C, Lee S, Kim J, Oh S-W. Synergistic antimicrobial effects of organic acids in combination with carvacrol against Shigella Sonnei. J Food Saf. 2016;36(3):360–366. doi:10.1111/jfs.12251
   Web of Science ®Google Scholar
• Balakrishnan S, Duraisamy S, Kasi M, Kandasamy S, Sarkar R, Kumarasamy A. Syntheses, physicochemical characterization, antibacterial studies on potassium morpholine dithiocarbamate nickel (II), copper (II) metal complexes and their ligands. Heliyon. 2019;5(5):e01687. doi:10.1016/j.heliyon.2019.e0168731193102
   PubMed Web of Science ®Google Scholar
• Saqib S, Munis MFH, Zaman W, et al. Synthesis, characterization and use of iron oxide nano particles for antibacterial activity. Microsc Res Tech. 2019;82(4):415–420. doi:10.1002/jemt.2318230565799
   PubMed Web of Science ®Google Scholar
• Babaei S, Bajelani F, Mansourizaveleh O, Abbasi A, Oubari F. A study of the bactericidal effect of copper oxide nanoparticles on Shigella Sonnei and Salmonella Typhimurium. J Babol Univ Med Sci. 2017;19(11):76–81. doi:10.18869/acadpub.jbums.19.11.76
   Google Scholar
• Kareem ZH, Shareef HK, Alkaim AF. Evaluation of antibacterial activity of Fe2 O3 nanoparticles against Shigella dysenteriae. J Pharm Sci Res. 2018;10(8):1980–1982.
   Google Scholar
• Mukherjee R, Dutta D, Patra M, Chatterjee B, Basu T. Nanonized tetracycline cures deadly diarrheal disease ‘shigellosis’ in mice, caused by multidrug-resistant Shigella flexneri 2a bacterial infection. Nanomedicine. 2018. doi:10.1016/j.nano.2018.11.004
   Web of Science ®Google Scholar
• Omara ST, Zawrah MF, Samy AA. Minimum bactericidal concentration of chemically synthesized silver nanoparticles against pathogenic Salmonella and Shigella strains isolated from layer poultry farms. J Appl Pharm Sci. 2017;7(8):214–221. doi:10.7324/JAPS.2017.70829
   Google Scholar
• Jamal M, Chaudhry WN, Hussain T, Das CR, Andleeb S. Characterization of new myoviridae bacteriophage WZ1 against multi-drug resistant (MDR) Shigella dysenteriae. J Basic Microbiol. 2015;55(4):420–431. doi:10.1002/jobm.20140068825557472
   PubMed Web of Science ®Google Scholar
• Goodridge LD. Bacteriophages for managing Shigella in various clinical and non-clinical settings. Bacteriophage. 2013;3(1):e25098. doi:10.4161/bact.2509823819110
   PubMedGoogle Scholar
• Jun JW, Yun SK, Kim HJ, Chai JY, Park SC. Characterization and complete genome sequence of a novel N4-like bacteriophage, pSb-1 infecting Shigella boydii. Res Microbiol. 2014;165(8):671–678. doi:10.1016/j.resmic.2014.09.00625283727
   PubMed Web of Science ®Google Scholar
• Mai V, Ukhanova M, Reinhard MK, Li M, Sulakvelidze A. Bacteriophage administration significantly reduces Shigella colonization and shedding by Shigella-challenged mice without deleterious side effects and distortions in the gut microbiota. Bacteriophage. 2015;5(4):e1088124. doi:10.1080/21597081.2015.108812426909243
   PubMedGoogle Scholar
• Tang SS, Biswas SK, Tan WS, Saha AK, Leo BF. Efficacy and potential of phage therapy against multidrug resistant Shigella spp. PeerJ. 2019;7:e6225. doi:10.7717/peerj.622530984476
   PubMed Web of Science ®Google Scholar
• Pozsgay V, Kubler-Kielb J, Schneerson R, Robbins JB. Effect of the nonreducing end of Shigella dysenteriae type 1 O-specific oligosaccharides on their immunogenicity as conjugates in mice. Proc Natl Acad Sci U S A. 2007;104(36):14478–14482. doi:10.1073/pnas.070696910417726093
   PubMed Web of Science ®Google Scholar
• Phalipon A, Costachel C, Grandjean C, et al. Characterization of functional oligosaccharide mimics of the Shigella flexneri serotype 2a O-antigen: implications for the development of a chemically defined glycoconjugate vaccine. J Immunol. 2006;176(3):1686–1694. doi:10.4049/jimmunol.176.3.168616424198
   PubMed Web of Science ®Google Scholar
• Ranallo RT, Fonseka S, Boren TL, et al. Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: a new combination of gene deletions for 2nd generation live attenuated vaccine candidates. Vaccine. 2012;30(34):5159–5171. doi:10.1016/j.vaccine.2012.05.00322658966
   PubMed Web of Science ®Google Scholar
• Raqib R, Sarker P, Zaman K, et al. A phase I trial of WRSS1, a Shigella sonnei live oral vaccine in Bangladeshi adults and children. Hum Vaccin Immunother. 2019:1–12. doi:10.1080/21645515.2019.1575165.
   Web of Science ®Google Scholar
• Heine SJ, Diaz-McNair J, Andar AU, et al. Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes. J Immunol. 2014;192(4):1630–1640. doi:10.4049/jimmunol.130274324453241
   PubMed Web of Science ®Google Scholar
• DeLaine BC, Wu T, Grassel CL, et al. Characterization of a multicomponent live, attenuated Shigella flexneri vaccine. Pathog Dis. 2016;74(5). doi:10.1093/femspd/ftw034
   Web of Science ®Google Scholar
• Toapanta FR, Bernal PJ, Kotloff KL, Levine MM, Sztein MB. T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans. J Transl Med. 2018;16(1):61. doi:10.1186/s12967-018-1439-129534721
   PubMed Web of Science ®Google Scholar
• Mitobe J, Sinha R, Mitra S, et al. An attenuated Shigella mutant lacking the RNA-binding protein Hfq provides cross-protection against Shigella strains of broad serotype. PLoS Negl Trop Dis. 2017;11(7):e0005728. doi:10.1371/journal.pntd.000572828727722
   PubMed Web of Science ®Google Scholar
• Wu Y, Chakravarty S, Li M, Wai TT, Hoffman SL, Sim BK. Development of a live attenuated bivalent oral vaccine against Shigella sonnei Shigellosis and Typhoid Fever. J Infect Dis. 2017;215(2):259–268. doi:10.1093/infdis/jiw52827803169
   PubMed Web of Science ®Google Scholar
• Yagnik B, Sharma D, Padh H, Desai P. Immunization with r-Lactococcus lactis expressing outer membrane protein A of Shigella dysenteriae type-1: evaluation of oral and intranasal route of administration. J Appl Microbiol. 2017;122(2):493–505. doi:10.1111/jam.1335327860045
   PubMed Web of Science ®Google Scholar
• Kaminski RW, Wu M, Turbyfill KR, et al. Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine. Clin Vaccine Immunol. 2014;21(3):366–382. doi:10.1128/cvi.00683-1324403527
   PubMedGoogle Scholar
• Nag D, Sinha R, Mitra S, et al. Heat killed multi-serotype Shigella immunogens induced humoral immunity and protection against heterologous challenge in rabbit model. Immunobiology. 2015;220(11):1275–1283. doi:10.1016/j.imbio.2015.07.00226210044
   PubMed Web of Science ®Google Scholar
• Turbyfill KR, Clarkson KA, Vortherms AR, Oaks EV, Kaminski RW, Pasetti MF. Assembly, biochemical characterization, immunogenicity, adjuvanticity, and efficacy of Shigella artificial invaplex. mSphere. 2018;3(2). doi:10.1128/mSphere.00583-17
   Web of Science ®Google Scholar
• Obiero CW, Ndiaye AGW, Scire AS, et al. A phase 2a randomized study to evaluate the safety and immunogenicity of the 1790GAHB generalized modules for membrane antigen vaccine against Shigella sonnei administered intramuscularly to adults from a Shigellosis-endemic Country. Front Immunol. 2017;8:1884. doi:10.3389/fimmu.2017.0188429375556
   PubMed Web of Science ®Google Scholar
• Camacho AI, Irache JM, de Souza J, Sanchez-Gomez S, Gamazo C. Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice. Vaccine. 2013;31(32):3288–3294. doi:10.1016/j.vaccine.2013.05.02023727423
   PubMed Web of Science ®Google Scholar
• Barel LA, Mulard LA. Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human. Hum Vaccin Immunother. 2019. doi:10.1080/21645515.2019.1606972
   Web of Science ®Google Scholar
• Passwell JH, Ashkenzi S, Banet-Levi Y, et al. Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children. Vaccine. 2010;28(10):2231–2235. doi:10.1016/j.vaccine.2009.12.05020056180
   PubMed Web of Science ®Google Scholar
• Taneja N, Mewara A, Kumar A, Verma G, Sharma M. Cephalosporin-resistant Shigella flexneri over 9 years (2001-09) in India. J Antimicrob Chemother. 2012;67(6):1347–1353. doi:10.1093/jac/dks06122410619
   PubMed Web of Science ®Google Scholar
• Nagano Y, Nagano N, Wachino J, Ishikawa K, Arakawa Y. Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime. Antimicrob Agents Chemother. 2009;53(1):69–74. doi:10.1128/aac.00227-0818955524
   PubMed Web of Science ®Google Scholar
• Schumacher H, Nir M, Mansa B, Grassy A. beta-lactamases in Shigella. Apmis. 1992;100(10):954–956.1445702
   PubMed Web of Science ®Google Scholar
• Qin T, Bi R, Fan W, Kang H, Ma P, Gu B. Novel mutations in quinolone resistance-determining regions of gyrA, gyrB, parC and parE in Shigella flexneri clinical isolates from eastern Chinese populations between 2001 and 2011. Eur J Clin Microbiol Infect Dis. 2016;35(12):2037–2045. doi:10.1007/s10096-016-2761-227620866
   PubMed Web of Science ®Google Scholar
• Chowdhury FM, Rahman MZ, Sarkar MMH, et al. Protection against shigellosis caused by Shigella dysenteriae serotype 4 in guinea pigs using Escherichia albertii DM104 as a live vaccine candidate strain. Acta Microbiol Immunol Hung. 2017;64(2):151–164. doi:10.1556/030.64.2017.01528597684
   PubMed Web of Science ®Google Scholar
• McKenzie R, Venkatesan MM, Wolf MK, et al. Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate. Vaccine. 2008;26(26):3291–3296. doi:10.1016/j.vaccine.2008.03.07918468742
   PubMed Web of Science ®Google Scholar
• Rahman KM, Arifeen SE, Zaman K, et al. Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh. Vaccine. 2011;29(6):1347–1354. doi:10.1016/j.vaccine.2010.10.03521040694
   PubMed Web of Science ®Google Scholar
• Launay O, Sadorge C, Jolly N, et al. Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a phase 2, randomized, double-blind placebo-controlled trial. Vaccine. 2009;27(8):1184–1191. doi:10.1016/j.vaccine.2008.12.02119135496
   PubMed Web of Science ®Google Scholar
• Noriega FR, Losonsky G, Wang JY, Formal SB, Levine MM. Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli. Infect Immun. 1996;64(1):23–27.8557344
   PubMed Web of Science ®Google Scholar
• Nag D, Koley H, Sinha R, et al. Immunization of mice with a live transconjugant Shigella hybrid strain induced Th1 and Th17 cell-mediated immune responses and confirmed passive protection against heterologous Shigellae. Scand J Immunol. 2016;83(2):92–101. doi:10.1111/sji.1239426478541
   PubMed Web of Science ®Google Scholar
• Formal SB, Hale TL, Kapfer C, et al. Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen. Infect Immun. 1984;46(2):465–469.6389344
   PubMed Web of Science ®Google Scholar
• Kim MJ, Moon Y-H, Kim H, et al. Cross-protective Shigella whole-cell vaccine with a truncated O-polysaccharide chain. Front Microbiol. 2018;9:2609. doi:10.3389/fmicb.2018.0260930429838
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Harro C, DeNearing B, et al. Evaluation of the safety, tolerability, and immunogenicity of an oral, inactivated whole-cell Shigella flexneri 2a vaccine in healthy adult subjects. Clin Vaccine Immunol. 2016;23(4):315–325. doi:10.1128/cvi.00608-1526865592
   PubMedGoogle Scholar
• Chitradevi STS, Kaur G, Sivaramakrishna U, Singh D, Bansal A. Development of recombinant vaccine candidate molecule against Shigella infection. Vaccine. 2016;34(44):5376–5383. doi:10.1016/j.vaccine.2016.08.03427591952
   PubMed Web of Science ®Google Scholar
• Hatz CF, Bally B, Rohrer S, et al. Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: a single blind, partially randomized phase I study. Vaccine. 2015;33(36):4594–4601. doi:10.1016/j.vaccine.2015.06.10226162850
   PubMed Web of Science ®Google Scholar
• Pozsgay V, Chu C, Pannell L, Wolfe J, Robbins JB, Schneerson R. Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1. Proc Natl Acad Sci U S A. 1999;96(9):5194–5197. doi:10.1073/pnas.96.9.519410220442
   PubMed Web of Science ®Google Scholar
• Mitra S, Sinha R, Mitobe J, Koley H. Development of a cost-effective vaccine candidate with outer membrane vesicles of a tolA-disrupted Shigella boydii strain. Vaccine. 2016;34(15):1839–1846. doi:10.1016/j.vaccine.2016.02.01826878295
   PubMed Web of Science ®Google Scholar